Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
The FDA is casting a wide net to fill seats on its advisory committees, seeking scientists, medical experts, and consumer representatives from across the country. Vacancies span oncology, cardiology, neurology, genetics, and medical devices. Nominations — including self-nominations — are open on a rolling basis, with deadlines in November for first consideration.
The US Food and Drug Administration has kicked off a nationwide recruitment campaign to fill current and anticipated vacancies on its advisory committees — the panels that review scientific evidence and provide independent recommendations on drugs, vaccines, and other regulated products. Acting FDA Commissioner Kyle Diamantas framed the push as an open invitation: "We are actively inviting people from across the country who are on the forefront of their fields."
Advisory committee members can include physicians, researchers, statisticians, patient advocates, and consumer representatives. Their recommendations, while influential, are not binding on the agency. The FDA will accept nominations on a rolling basis, including self-nominations.
By the Numbers
Why it matters: Advisory committees play a critical role in shaping FDA decisions on some of the most consequential medical products on the market. A robust, diverse panel membership helps ensure those decisions are grounded in the latest science and reflect a broad range of perspectives.
